Article
The structural basis for LRRK2’s activation and autoinhibition
2026-06-03
Abstract excerpt
<h4>SUMMARY</h4> Mutations in Leucine-Rich Repeat Kinase 2 (LRRK2) are the second most common cause of autosomal-dominant Parkinson’s disease (PD), and increased LRRK2 kinase activity is also observed in idiopathic PD, making LRRK2 a major actionable therapeutic target. LRRK2 is a 286-kDa multidomain enzyme containing a Ras-like GTPase (ROC) and a kinase domain. Using cryo-EM, biochemical reconstitution, and cell...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- c2e4f346-b2e1-56b9-9a70-155f6e606beb
- DOI
- 10.64898/2026.05.31.729085
